mortgagesolutions.co.uk45 分钟
TSLE2025: Second charge is on the rise with key opportunities being debt consolidation and ...
The second charge market is on the increase and key opportunities for brokers will be debt consolidation and green ...
Most patients on Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease achieved sustained ...
Eli Lilly and Company (NYSE: LLY) announced results from the VIVID-2 open-label extension study, which showed the majority of ...